http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105377846-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a90b0b7934f5ced4751a612dabcdf0e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N45-00
filingDate 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad0cf767416a7250a11d307fcb0471c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d4dc01f0d8ab807838af56d2d8eb149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c8fc3a9db91c7b907bb7c7cf08e57d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb43377704246653146c9c66d5cf393b
publicationDate 2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105377846-A
titleOfInvention organic compound
abstract The present invention provides PDE1 inhibitors of formula I, processes for their production, their use as medicaments and pharmaceutical compositions comprising them.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112189013-A
priorityDate 2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102232077-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101970444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012053190-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008188492-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410249106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466470285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468348225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467497897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468262822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90409046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410249087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86279161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468183794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86279223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410249097

Total number of triples: 49.